BYCONIQ

pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, inflammation, inflammatory diseases and disorders, neurological diseases and disorders and metabolic diseases and disorders